Apellis Pharmaceuticals

Biotechnology Research · 501 Employees
Phone Number: 5022414114
Email Address: info@apellis.com
  • Overview
  • Job Postings
  • Employees
Access 485 Verified Employees Profiles for Apellis PharmaceuticalsUnlock Free Contacts Now
About
At Apellis, we are committed to developing transformative therapies for people living with a broad range of debilitating diseases by controlling complement, part of the body’s immune system. Our work is rooted centrally at C3, which is the only target in the complement cascade that addresses all three pathways that can drive disease. Targeting C3 has broad platform potential to treat many diseases where patients have few or no treatment options available. Our programs across ophthalmology, nephrology, hematology, and neurology are further exploring what is possible by targeting C3. You can view our community guidelines here: Community guidelines: http://bit.ly/476Q8
Year Founded
2008
Social Media
LinkedinTwitter
Industry
Biotechnology Research
HQ Location
100 Fifth Ave 3rd Floor Waltham, MA 02451, US
Keywords
Targeted C3 TherapiesComplement SystemHematologyOphthalmologyNephrologyParoxysmal Nocturnal Hemoglobinuria (PNH)Geographic Atrophy (GA)C3 Glomerulopathy (C3G)Cold Agglutinin Disease (CAD)Gene Therapy
Location
3
  • 100 Fifth Ave 3rd Floor Waltham, MA 02451, US
  • 720 Market Street 5th Floor San Francisco, California 94102, US
  • Zählerweg 10 Zug, 6300, CH

Email Formats

Sign up for free credits and discover verified email addresses of Apellis Pharmaceuticals
FormatExamples
first + last
andywarhol@apellis.com
first_initial + last
awarhol@apellis.com
first + last_initial
andyw@apellis.com
first
andy@apellis.com
last
warhol@apellis.com
Get Verified Emails for 485 Apellis Pharmaceuticals Employees

Frequently Asked Questions

Learn More about Apellis Pharmaceuticals

Similar Companies

Biotechnology Research

Get key business info for Apellis Pharmaceuticals and other 100M companies. Start your seach.

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.